Todd Mendelson

Title: Todd Mendelson: Innovator in Anti-Thrombogenic Medical Devices

Introduction

Todd Mendelson is a prominent inventor based in Mission Viejo, CA (US). He has made significant contributions to the field of medical devices, particularly in the development of anti-thrombogenic technologies. With a total of 5 patents to his name, Mendelson's work is paving the way for advancements in medical treatments.

Latest Patents

Mendelson's latest patents focus on anti-thrombogenic medical devices. These devices include a tubular member with a plurality of braided filaments. Each filament crosses another at respective crossing points, forming a sidewall with a plurality of pores. These pores are specifically sized to inhibit blood flow into an aneurysm, promoting thrombosis and healing when positioned adjacent to the aneurysm. The average pore size is less than or equal to about 500 microns when the tubular member is in an expanded state. The filaments possess antithrombogenic surfaces, enhancing the device's effectiveness while ensuring that fewer than 5% of the crossing points have webs formed by antithrombogenic material.

Career Highlights

Mendelson is currently employed at Covidien LP, where he continues to innovate in the medical device sector. His work has garnered attention for its potential to improve patient outcomes in vascular treatments.

Collaborations

Throughout his career, Mendelson has collaborated with notable colleagues, including John Wainwright and Kurt Haggstrom. These partnerships have contributed to the development of cutting-edge medical technologies.

Conclusion

Todd Mendelson's contributions to anti-thrombogenic medical devices exemplify the impact of innovation in healthcare. His work not only advances medical technology but also enhances the quality of patient care.